outcomes and complications of implantable collamer lens and toric implantable collamer lens for the correction of high myopia with and without astigmatism (one year prospective study)

نویسندگان

سیدجواد هاشمیان

seyed javad hashemian فریبا بیگ زاده

fariba bigzadeh علیرضا فروتن

alireza foroutan شهراد تاج الدینی

shahrad tajoddini محمدجعفر قائم پناه

چکیده

purpose : to evaluate the efficacy, safety, predictability and stability of implantable collamer lens (icl) and toric icl for the treat­ment of high myopia and high myopic astigmatism methods : in this prospective nonrandomized clinical trial, 95 eyes of 51 patients who underwent icl (31 eyes) and toric icl (64 eyes) implantations were participate in eye research center, department of ophthalmology, rasoul akram hospital, tehran university of medical sciences and negah eye hospital, tehran, iran. uncorrected visual accuity (ucva), best spectacle corrected visual acuity (bscva), manifest refraction, adverse events and com­plications were evaluated at 5th day and 2, 6 and 12 months postoperation. results : the mean preoperative manifest refractive spherical equivalents (mrse) were -11.75±4.63 d (diopter) (-5.0 to -22.0) in icl group and -11.67±3.99 d (-3.0 to -21.0) in toric icl group. mean residual refractive spherical equivalent were -0.68±1.07 d at 5th day, -0.86±1.07 d at 2 months, -0.65±0.72 d at 6 months, -0.71±0.78 d at one year in icl group and -0.69±1.03 d, -0.59±0.84 d, -0.71±0.76 d and -0.89±0.68 d in toric icl group, respectively. preoperative cylinder in toric icl group was -3.25±1.29 d (-2.0 to -6.0) and after operation was -0.81±0.63 d, -0.75±0.67 d, -0.93±0.70 d, -0.94±0.61 d, respectively. at 2 months after operation, the ucva was 20/40 or better in 74.3% in icl group and 74.6 % in toric icl group (efficacy=1.092 and 1.154, respectively). 71.0% and 68.2% were within ±0.5 d and 77.5% and 85.7% were within ±1.0 d of emmetropia, respectively. 58.1% and 63.6% gained one or more lines (safety=1.18 and 1.24) two months after operation. at 2 months after operation, 81%, of eyes in toric icl group had <1.0 d and 95.3% <1.5 d cylinder. no operative and postoperative complications or adverse events were observed. one eye (1.05%) developed asymptomatic (trace) anterior subcapsular opacities. conclusion : icl and toric icl implantations were effec­tive, predictable, and safe procedures for the treatment of high myopia and high myopic astigmatism.    iranian journal of ophthalmology 201325(1):8-18 © 2013 by the iranian society of ophthalmology

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

outcomes and complications of implantable collamer lens and toric implantable collamer lens for the correction of high myopia with and without astigmatism

purpose: to evaluate the efficacy, safety, predictability and stability of implantable collamer lens (icl) and toric icl for the treat­ment of high myopia and high myopic astigmatism, one year prospective study. methods: in this prospective nonrandomized clinical trial, 95 eyes of 51 patients that had icl (31 eyes) and toric icl (64 eyes) were participate in eye research center, department of o...

متن کامل

Visual outcomes and patient satisfaction after implantable collamer lens and Toric implantable collamer lens correction for moderate to high myopia and myopic astigmatism.

OBJECTIVE To compare preoperative and postoperative visual outcomes, determine patient's satisfaction, and evaluate visual symptoms after implantable collamer lens (ICL) implantation. METHODS One hundred and twelve patients with myopia between -2.75 and -19.50 diopter had ICL or Toric ICL (TICL) implantation. The implantations were carried out at the Cornea and Refractive Unit, Magrabi Eye Ho...

متن کامل

Toric phakic implantable collamer lens for correction of astigmatism: 1-year outcomes

PURPOSE The purpose of this study was to assess predictability, efficacy, safety and stability in patients who received a toric implantable collamer lens to correct moderate to high myopic astigmatism. METHODS Forty-three eyes of 23 patients underwent implantation of a toric implantable collamer lens (STAAR Surgical Inc) for astigmatism correction. Mean spherical refraction was -4. 98 ± 3.49 ...

متن کامل

Visual Outcomes of Toric Implantable Collamer Lens for Correction of Compound Myopic Astigmatism

Purpose: To assess the visual and refractive outcomes after implantation of Toric Implantable Collamer Lens (T-ICL) in compound myopic astigmatism Methods: In this prospective study, 28 eyes with manifest refraction spherical equivalent (MRSE) errors of -10.94±4.09 diopter (D) and mean cylindrical errors of -3.47±1.39 D underwent T-ICL implantation. Six months after surgery, best corrected and ...

متن کامل

visual outcomes of toric implantable collamer lens for correction of compound myopic astigmatism

purpose : to assess the visual and refractive outcomes after implantation of toric implantable collamer lens (t-icl) in compound myopic astigmatism methods : in this prospective study, 28 eyes with manifest refraction spherical equivalent (mrse) errors of -10.94±4.09 diopter (d) and mean cylindrical errors of -3.47±1.39 d underwent t-icl implantation. six months after surgery, best corrected an...

متن کامل

Standardized analyses of correction of astigmatism with the visian toric phakic implantable collamer lens.

PURPOSE To demonstrate the methodology described by the American National Standards Institute (ANSI) Standard Subcommittee on Astigmatism Analysis reporting a standardized method of presenting astigmatism data by laser systems that reshape the cornea also applies to toric phakic intraocular lens (IOL) data. METHODS The U.S. Food and Drug Administration trial of the Visian Toric Implantable Co...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of current ophthalmology

جلد ۲۵، شماره ۱، صفحات ۸-۱۸

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023